References

Baseggio Conrado A, Ierodiakonou D, Gowland MH, Boyle RJ, Turner PJ. Food anaphylaxis in the United Kingdom: analysis of national data, 1998-2018. BMJ. 2021; 372 https://doi.org/10.1136/bmj.n251

Cardona V, Ansotegui IJ, Ebisawa M World allergy organization anaphylaxis guidance 2020. World Allergy Organ J. 2020; 13:(10) https://doi.org/10.1016/j.waojou.2020.100472

Gupta R, Sheikh A, Strachan DP, Anderson HR. Burden of allergic disease in the UK: secondary analyses of national databases. Clinical Experimental Allergy. 2004; 34:(4)520-526 https://doi.org/10.1111/j.1365-2222.2004.1935.x

Kemp SF, Lockey RF. Anaphylaxis: A review of causes and mechanisms. J Allergy Clin Immunol. 2002; 110:(3)341-348 https://doi.org/10.1067/mai.2002.126811

Medicines and Healthcare products Regulatory Agency. Adrenaline auto-injectors: recent action taken to support safety. 2019. https://www.gov.uk/drug-safety-update/adrenaline-auto-injectors-recent-action-taken-to-support-safety (accessed 6 May 2021)

National Institute for Health and Care Excellence. Food allergy in under 19s: assessment and diagnosis. 2011a. https://www.nice.org.uk/guidance/cg116/resources/food-allergy-in-under-19s-assessment-and-diagnosis-pdf-35109392795845 (accessed 6 May 2021)

National Institute for Health and Care Excellence. Anaphylaxis: assessment and referral after emergency treatment. 2011b. https://www.nice.org.uk/guidance/cg134/resources/anaphylaxis-assessment-and-referral-after-emergency-treatment-pdf-35109510368965 (accessed 6 May 2021)

National Institute for Health and Care Excellence. Anaphylaxis: assessment and referral after emergency treatment. 2020. http://www.nice.org.uk/guidance/CG134 (accessed 17 May 2021)

Panesar SS, Javad S, de Silva D The epidemiology of anaphylaxis in Europe: a systematic review. Allergy. 2013; 68:(11)1353-1361 https://doi.org/10.1111/all.12272

Resuscitation Council UK. Emergency treatment of anaphylactic reactions: Guidelines for healthcare providers. 2021. https://www.resus.org.uk/media/337/download (accessed 6 May 2021)

Soar J, Pumphrey R, Cant A Working Group of the Resuscitation Council (UK). Emergency treatment of anaphylactic reactions--guidelines for healthcare providers. Resuscitation. 2008; 77:(2)157-169 https://doi.org/10.1016/j.resuscitation.2008.02.001

Turner PJ, Gowland MH, Sharma V Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012. J Allergy Clin Immunol. 2015; 135:(4)956-963.e1 https://doi.org/10.1016/j.jaci.2014.10.021

Turner PJ, Jerschow E, Umasunthar T, Lin R, Campbell DE, Boyle RJ. Fatal Anaphylaxis: Mortality Rate and Risk Factors. J Allergy Clin Immunol Pract. 2017; 5:(5)1169-1178 https://doi.org/10.1016/j.jaip.2017.06.031

Anaphylaxis: how to recognise and manage in primary care

02 June 2021
Volume 32 · Issue 6

Abstract

Anaphylaxis is a life-threatening emergency. Hannah Kramer and Rebecca Batt explain how correct diagnosis, avoidance and patient education are fundamental in reducing risk

Anaphylaxis is a serious systemic hypersensitivity reaction that is usually rapid in onset and can cause death. It is an immune-mediated reaction, which typically occurs when a person is exposed to a trigger, for example a food, drug, or insect sting. This article aims to assist with the recognition of symptoms and to guide management of anaphylaxis in primary care. Beyond the acute, the practice nurse can play a key role in helping patients to manage their allergies in the long-term, particularly for those who are most vulnerable. Patients should be supported in understanding how best to avoid their triggers, in managing their emergency medication, and in the importance of good asthma control.

Anaphylaxis is an immune-mediated reaction, which typically occurs when a person is exposed to a trigger, for example a food, drug, or insect sting. Onset of symptoms after exposure to a trigger can be within minutes or up to several hours later – this can be influenced by the route of exposure to the trigger, or the amount of allergen they are exposed to. In some instances, there can be no trigger established: this is known as ‘idiopathic anaphylaxis’ (Resuscitation Council United Kingdom [RCUK], 2021).

Anaphylaxis can be defined as:

‘a serious systemic hypersensitivity reaction that is usually rapid in onset and may cause death. Anaphylaxis is characterized by potentially life-threatening compromise in airway, breathing and/or the circulation, and may occur without typical skin features or circulatory shock being present.’

(Cardona et al, 2020)

It is estimated that 1 in 300 people in Europe will experience anaphylaxis in their lifetime (Panesar et al, 2013). The incidence of anaphylaxis has increased significantly in recent years; it is estimated that there are around 20 deaths each year due to anaphylaxis in the UK (Turner et al, 2015). Therefore, it is important that health professionals can recognise and manage this life-threatening emergency. It is recommended that staff who give immunisations should have annual updates in the treatment of anaphylaxis (RCUK, 2021).

Register now to continue reading

Thank you for visiting Practice Nursing and reading some of our peer-reviewed resources for general practice nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month